Estimation of radiation dose-reduction factor for cerium oxide nanoparticles in MRC-5 human lung fibroblastic cells and MCF-7 breast-cancer cells

References

• Farhood B, Geraily G, Alizadeh A. Incidence and mortality of various cancers in Iran and compare to other countries: a review article. Iran J Public Health. 2018;47:309–316.
   PubMed Web of Science ®Google Scholar
• Yahyapour R, Motevaseli E, Rezaeyan A, et al. Reduction-oxidation (redox) system in radiation-induced normal tissue injury: molecular mechanisms and implications in radiation therapeutics. Clin Transl Oncol. 2018;20:975–988.
   PubMed Web of Science ®Google Scholar
• Bahreyni Toossi MT, Soleymanifard S, Farhood B, et al. Assessment of accuracy of out-of-field dose calculations by TiGRT treatment planning system in radiotherapy. J Cancer Res Ther. 2018;14:634–639.
   PubMed Web of Science ®Google Scholar
• Baskar R, Lee KA, Yeo R, et al. Cancer and radiation therapy: current advances and future directions. Int J Med Sci. 2012;9:193–199.
   PubMed Web of Science ®Google Scholar
• Kumar S. Second malignant neoplasms following radiotherapy. Ijerph. 2012;9:4744–4759.
   Web of Science ®Google Scholar
• Supramaniam R. New malignancies among cancer survivors: SEER cancer registries, 1973–2000. J Epidemiol Community Health. 2008;62:375–376.
   Google Scholar
• Bertelsen A, Hansen CR, Johansen J, et al. Single arc volumetric modulated arc therapy of head and neck cancer. Radiother Oncol. 2010;95:142–148.
   PubMed Web of Science ®Google Scholar
• Small WJR. Image-Guided Radiation Therapy. In: Youl M, Brock KK, Dawson LA (eds). Clinical Radiation Oncology: Indications, Techniques, and Results. Hoboken, NJ: John Wiley & Sons, Inc; 2017. p. 83–98.
   Google Scholar
• Khan FM, Gibbons JP. Khan's the Physics of Radiation Therapy. Philadelphia: Lippincott Williams & Wilkins; 2014.
   Google Scholar
• Sountoulides P, Koletsas N, Kikidakis D, et al. Secondary malignancies following radiotherapy for prostate cancer. Ther Adv Urol. 2010;2:119–125.
   PubMedGoogle Scholar
• Velpula N, Ugrappa S, Kodangal S. A role of radioprotective agents in cancer therapeutics: a review. Int J Basic Clin Pharmacol. 2013;2:677–682.
   Google Scholar
• Farhood B, Goradel NH, Mortezaee K, et al. Intercellular communications-redox interactions in radiation toxicity; potential targets for radiation mitigation. J Cell Commun Signal. 2018; (in press).
   PubMed Web of Science ®Google Scholar
• Najafi M, Motevaseli E, Shirazi A, et al. Mechanisms of inflammatory responses to radiation and normal tissues toxicity: clinical implications. Int J Radiat Biol. 2018;94:335–356.
   PubMed Web of Science ®Google Scholar
• Yahyapour R, Shabeeb D, Cheki M, et al. Radiation protection and mitigation by natural antioxidants and flavonoids; implications to radiotherapy and radiation disasters. Cmp. 2018;11:285– 304.
   Web of Science ®Google Scholar
• Niu J, Wang K, Kolattukudy PE. Cerium oxide nanoparticles inhibit oxidative stress and nuclear factor-κB activation in H9c2 cardiomyocytes exposed to cigarette smoke extract . J Pharmacol Exp Ther. 2011;338:53–61.
   PubMed Web of Science ®Google Scholar
• Pešić M, Podolski-Renić A, Stojković S, et al. Anti-cancer effects of cerium oxide nanoparticles and its intracellular redox activity. Chem Biol Interac. 2015;232:85–93.
   PubMed Web of Science ®Google Scholar
• Baker CH. Harnessing cerium oxide nanoparticles to protect normal tissue from radiation damage. Transl Cancer Res. 2013;2:343–358.
   Web of Science ®Google Scholar
• Grantzau T, Overgaard J. Risk of second non-breast cancer after radiotherapy for breast cancer: a systematic review and meta-analysis of 762,468 patients. Radiother Oncol. 2015;114:56–65.
   PubMed Web of Science ®Google Scholar
• Valentin J. The 2007 Recommendations of the International Commission on Radiological Protection. Amsterdam: Elsevier Oxford; 2007.
   Google Scholar
• Andreassi MG, Piccaluga E, Gargani L, et al. Subclinical carotid atherosclerosis and early vascular aging from long-term low-dose ionizing radiation exposure: a genetic, telomere, and vascular ultrasound study in cardiac catheterization laboratory staff. JACC Cardiovas Interv. 2015;8:616–627.
   PubMed Web of Science ®Google Scholar
• Hall EJ, Giaccia AJ. Radiobiology for the Radiologist. Philadelphia: Lippincott Williams & Wilkins; 2006.
   Google Scholar
• Nadi S, Monfared AS, Mozdarani H, et al. Effects of arbutin on radiation-induced micronuclei in mice bone marrow cells and its definite dose reduction factor. Iran J Med Sci. 2016;41:180–185.
   PubMed Web of Science ®Google Scholar
• Yin L, Wang Y, Pang G, et al. Sonochemical synthesis of cerium oxide nanoparticles-effect of additives and quantum size effect. J Colloid Interface Sci. 2002;246:78–84.
   PubMed Web of Science ®Google Scholar
• Goharshadi EK, Samiee S, Nancarrow P. Fabrication of cerium oxide nanoparticles: characterization and optical properties. J Colloid Interface Sci. 2011;356:473–480.
   PubMed Web of Science ®Google Scholar
• Lin W, Huang Y-w, Zhou X-D, et al. Toxicity of cerium oxide nanoparticles in human lung cancer cells. Int J Toxicol. 2006;25:451–457.
   PubMed Web of Science ®Google Scholar
• Park E-J, Choi J, Park Y-K, et al. Oxidative stress induced by cerium oxide nanoparticles in cultured BEAS-2B cells. Toxicology. 2008;245:90–100.
   PubMed Web of Science ®Google Scholar
• Rubio L, Annangi B, Vila L, et al. Antioxidant and anti-genotoxic properties of cerium oxide nanoparticles in a pulmonary-like cell system. Arch Toxicol. 2016;90:269–278.
   PubMed Web of Science ®Google Scholar
• Bystrzejewska-Piotrowska G, Golimowski J, Urban PL. Nanoparticles: their potential toxicity, waste and environmental management. Waste Manag. 2009;29:2587–2595.
   PubMed Web of Science ®Google Scholar
• Colon J, Hsieh N, Ferguson A, et al. Cerium oxide nanoparticles protect gastrointestinal epithelium from radiation-induced damage by reduction of reactive oxygen species and upregulation of superoxide dismutase 2. Nanomedicine. 2010;6:698–705.
   PubMed Web of Science ®Google Scholar
• Ouyang Z, Mainali MK, Sinha N, et al. Potential of using cerium oxide nanoparticles for protecting healthy tissue during accelerated partial breast irradiation (APBI). Phys Med. 2016;32:631–635.
   PubMed Web of Science ®Google Scholar
• Goushbolagh NA, Farhood B, Astani A, et al. Quantitative cytotoxicity, cellular uptake and radioprotection effect of cerium oxide nanoparticles in MRC-5 normal cells and MCF-7 cancerous cells. Bionanosci. 2018;8:769–777.
   Web of Science ®Google Scholar
• Popov A, Zaichkina S, Popova N, et al. Radioprotective effects of ultra-small citrate-stabilized cerium oxide nanoparticles in vitro and in vivo. RSC Adv. 2016;6:106141–106149.
   Web of Science ®Google Scholar
• Tarnuzzer RW, Colon J, Patil S, et al. Vacancy engineered ceria nanostructures for protection from radiation-induced cellular damage. Nano Lett. 2005;5:2573–25737.
   PubMed Web of Science ®Google Scholar
• Briggs A, Corde S, Oktaria S, et al. Cerium oxide nanoparticles: influence of the high-Z component revealed on radioresistant 9L cell survival under X-ray irradiation. Nanomedicine. 2013;9:1098–1105.
   PubMed Web of Science ®Google Scholar
• Colon J, Herrera L, Smith J, et al. Protection from radiation-induced pneumonitis using cerium oxide nanoparticles. Nanomedicine. 2009;5:225–231.
   PubMed Web of Science ®Google Scholar
• Khan FM, Gerbi BJ. Treatment Planning in Radiation Oncology. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2012.
   Google Scholar
• Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21:109–122.
   PubMed Web of Science ®Google Scholar